Change to Interim Results announcement date
Summary by AI BETAClose X
Spire Healthcare Group plc has announced a change to the release date of its interim results for the six months ended 30 June 2026. The company now expects to announce these results by 30 September 2026, a shift from the previously scheduled date of 9 September 2026. This announcement does not include any financial figures for the interim period.
Spire Healthcare Group PLC
21 August 2026
21 August 2026
Spire Healthcare Group plc
("Spire Healthcare", the "Company")
Change to Interim Results announcement date
Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, announces that its Interim Results for the six months ended 30 June 2026 are expected to be released by 30 September 2026, and not on 9 September 2026 as previously announced.
ENQUIRIES:
For further information please contact:
Spire Healthcare Group plcAmie Gramlick, Director of Commercial Finance & Investor Relations |
+44 (0)80 0169 1777 |
Brunswick (Communications adviser)Simon Sporborg / Ayesha Bharmal |
+44 (0)20 7404 5959 |
J.P. Morgan Cazenove (Financial adviser and joint corporate broker)James Mitford / Alia Malik / Nikhil Gondalia |
+44 (0)20 3493 8000 |
Berenberg (Joint corporate broker)Toby Flaux / Ben Wright / Detlir Elezi |
+44 (0)20 3207 7800 |
About Spire Healthcare
Spire Healthcare is a leading, independent healthcare group in the United Kingdom, running 38 hospitals and over 60 clinics across England, Wales and Scotland. Working in partnership with over 8,800 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1.36 million inpatients, outpatients and day case patients, and workplace health clients, in 2025. It is the leading private provider, by volume, of knee and hip operations in the United Kingdom.
It operates a network of private GPs and provides workplace health services to over 1,400 employers. It also delivers a range of private, NHS and employer-funded mental health, musculoskeletal and 3 dermatological services, and is the largest independent provider of NHS talking therapies in England.
Spire Healthcare's almost 100 well-located clinical sites deliver award-winning care for self-pay patients, the NHS, employers and private medical insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good,' 'Outstanding', or the equivalent by health inspectors in England, Wales and Scotland.
Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Public Policy Holding Company, Inc. (DI) (REG S, CAT3)
- 1 hour ago Pulsar Group
- 1 hour ago Mercia Asset Management
- 1 hour ago ITM Power
- 15 hours ago Oxford Nanopore Technologies